Prospective Clinical Assessment Study in Children With Hypochondroplasia

ClinicalTrials.gov ID: NCT06410976

Public ClinicalTrials.gov record NCT06410976. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 18, 2026, 9:06 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Prospective Clinical Assessment Study in Children With Hypochondroplasia: ACCEL

Study identification

NCT ID: NCT06410976
Recruitment status: Recruiting
Study type: Observational
Phase: Not listed
Lead sponsor: QED Therapeutics, a BridgeBio company; Industry
Enrollment: 150 participants

Conditions and interventions

Conditions

Hypochondroplasia

Interventions

Not listed

Eligibility (public fields only)

Age range: 30 Months to 16 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jun 4, 2024
Primary completion: Sep 30, 2026
Completion: Sep 30, 2026
Last update posted: Oct 9, 2025

2024 – 2026

United States locations

U.S. sites: 8
U.S. states: 8
U.S. cities: 8

Facility	City	State	ZIP	Site status
UCSF Benioff Children's Hospital	Oakland	California	94609	Recruiting
Childrens Hospital Colorado	Aurora	Colorado	80045	Recruiting
Children's National Hospital	Washington D.C.	District of Columbia	20010	Recruiting
Johns Hopkins School of Medicine	Baltimore	Maryland	21287	Recruiting
University of Missouri	Columbia	Missouri	65201	Recruiting
Cincinnati Children's Hospital Medical Center	Cincinnati	Ohio	45229	Recruiting
Vanderbilt University Medical Center	Nashville	Tennessee	37232	Recruiting
University of Wisconsin Madison - Waisman Center Bone Dysplasia Clinic	Madison	Wisconsin	53705	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06410976, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Oct 9, 2025 · Synced May 18, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06410976 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →